Plantar-Palmar Index Using SnapshotNIR Wins Best Clinical Research Abstract at SAWC 2025
Kent Imaging, a leading innovator in near-infrared spectroscopy (NIRS) medical imaging, is proud to announce that a research poster featuring its flagship technology, SnapshotNIR, was awarded Best Clinical Research Abstract at the Symposium of Advanced Wound Care (SAWC) Spring 2025, a premier conference for wound care professionals. Additionally, the lead author and primary investigator, Jonathan Niezgoda, OMS2, William Carey University College of Osteopathic Medicine, was recognized by being nominated for The Young Investigator Award.
The awarded poster titled, “The Plantar-Palmar Index with Near Infrared Spectroscopy Replaces the Ankle-Brachial Index for Noninvasive Evaluation of Vascular Perfusion and Peripheral Arterial Disease,” introduces a novel clinical protocol. The protocol uses NIRS to assess tissue oxygenation on plantar and palmer aspects of a patient, replacing the need to complete an ankle-brachial index (ABI) assessment.
By leveraging real-time tissue oxygenation data from SnapshotNIR, clinicians can calculate a Plantar-Palmar Index (PPI)—a potential alternative to the traditional ABI, which is often unreliable in patients with diabetes or arterial calcification. The resulting PPI strongly correlated with ABI and Pulse Volume Recordings (PVR), suggesting it may be a more reliable, efficient, and patient-friendly tool for evaluating Peripheral Arterial Disease (PAD).
The Plantar-Palmar Index from the poster.
“The Plantar-Palmar Index using SnapshotNIR represents a significant advancement in how we evaluate vascular oxygenation, especially in patients where traditional ABI methods are challenging and unreliable,” said Dr. Jeffrey Niezgoda, Chief Medical Officer of Wound Care and Limb Preservation at Kent Imaging, “This approach delivers objective, real-time data that is not only easier to obtain but also more actionable for clinicians making time-sensitive decisions for vascular diagnostics and ultimately, limb preservation.”
Looking ahead, this research can open doors into new assessment methods. The PPI using SnapshotNIR offers an accessible, reimbursable, and highly scalable alternative, which can be particularly impactful in wound care settings, where accurate oxygenation assessment is critical to healing outcomes and limb preservation.
“The development of the Plantar-Palmar index with SnapshotNIR represents a major step forward, overcoming limitations of traditional methods such as ABI,” said Dr. Glyn, Jones, Chief Medical Officer of Surgery at Kent Imaging, “With years of firsthand experience using these techniques, I see this innovation as a truly accessible and scalable way for clinicians to assess oxygenation directly at the bedside. It has the potential to make outdated approaches obsolete and meaningfully improve wound healing outcomes.”
Kent Imaging congratulates the researchers on their hard work and pioneering the way towards innovative medical assessments. The poster’s team of researchers included Jonathan Niezgoda, Francis Derk, DPM, Deparpan Das, MSc, Najratun Nayem Pinky, PhD, Sandeep Gopalakrishnan, PhD, and Jeffrey A. Niezgoda, MD, Chief Medical Officer at Kent Imaging.
Get the latest NIRS Roundtable Report from the expert panel.
See how melanin can impact NIRS technology and how SnapshotNIR is leading the way to improve this.
The unique Hemoglobin View on SnapshotNIR, your assessment shouldn’t stand on StO2 alone.
Enhance your documentation and protect your practice with NIRS imaging and SnapshotNIR